26.34
Amylyx Pharmaceuticals Inc (AMLX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
|
|
35.60%
21.93
|
16.17 | 15.39 | 16.17 | 15.64 |
| Costs And Expenses |
4.37%
45.69
|
43.78 | 36.60 | 36.03 | 42.86 |
| Operating Income/Loss |
4.37%
-45.69
|
-43.78 | -36.60 | -36.03 | -42.86 |
| Nonoperating Income/Loss |
9.02%
2.27
|
2.495 | 3.652 | 1.641 | 1.414 |
| Net Income/Loss |
5.18%
-43.42
|
-41.28 | -33.00 | -34.39 | -41.44 |
| Basic Average Shares |
0.57%
111.20
|
110.56 | 5.1481 | 93.33 | 89.14 |
| Diluted Average Shares |
0.57%
111.20
|
110.56 | 5.1481 | 93.33 | 89.14 |
| Basic Earnings Per Share |
5.41%
-0.39
|
-0.37 | -0.28 | -0.37 | -0.46 |
| Diluted Earnings Per Share |
5.41%
-0.39
|
-0.37 | -0.28 | -0.37 | -0.46 |
大文字化:
|
ボリューム (24 時間):